Loss of glymphatic homeostasis in heart failure

Marios Kritsilis1,2, Lotte Vanherle1,2,3, Marko Rosenholm4,5,6

  • 1Department of Experimental Medical Science, Lund University, 22362 Lund, Sweden.

PubMed

Insights

Heart failure impairs brain waste removal by altering glymphatic function, driven by increased arterial pulsatility but not proportional clearance. This suggests cerebral blood flow is key to preventing cognitive decline.

Area of Science:

  • Neuroscience
  • Cardiovascular Science
  • Physiology

Background:

  • Heart failure reduces cerebral blood flow, leading to cognitive decline and neurodegeneration.
  • The glymphatic system clears brain waste; its dysfunction is linked to neurodegeneration.

Purpose of the Study:

  • To investigate the impact of heart failure with reduced ejection fraction on glymphatic system function in a mouse model.
  • To explore the relationship between cerebral blood flow, arterial pulsatility, and glymphatic function in heart failure.

Main Methods:

  • Myocardial infarction induced heart failure in mice.
  • Dynamic contrast-enhanced MRI and two-photon microscopy assessed glymphatic influx and arterial pulsatility.
  • Brain parenchyma volume and protein clearance were quantified.

Main Results:

  • Heart failure increased glymphatic influx and cerebral arterial pulsatility 12 weeks post-myocardial infarction.
  • Protein clearance did not increase proportionally with influx, indicating dysregulated brain fluid dynamics.
  • A correlation was observed between brain clearance and cerebral blood flow.

Conclusions:

  • Cerebral blood flow is a critical regulator of glymphatic system function.
  • Heart failure-induced alterations in glymphatic dynamics may contribute to cognitive decline.
  • Further research is needed to understand cardiovascular disease effects on brain clearance mechanisms.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
339
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
516
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
382
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1